A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices

PURPOSE: We evaluated the incidence of febrile neutropenia (FN) and related clinical outcomes among patients treated with myelosuppressive chemotherapy for nonmyeloid malignancies who received pegfilgrastim on-body injector (OBI) or other options (Other) for FN prophylaxis. METHODS: In this prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Rifkin, Robert M., Crawford, Jeffrey, Mahtani, Reshma L., Dale, David C., Narang, Mohit, MacLaughlin, William W., Huynh, Chanh, Gawade, Prasad L., Lewis, Sandra, DeCosta, Lucy, Lawrence, Tatiana, Belani, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216302/
https://www.ncbi.nlm.nih.gov/pubmed/35732748
http://dx.doi.org/10.1007/s00520-022-07226-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216302/
https://www.ncbi.nlm.nih.gov/pubmed/35732748
http://dx.doi.org/10.1007/s00520-022-07226-9

Ejemplares similares